Related references
Note: Only part of the references are listed.Hepatic Steatosis and Steatohepatitis in a Large North American Cohort of Adults With Chronic Hepatitis B
Mandana Khalili et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2021)
Mechanisms and disease consequences of nonalcoholic fatty liver disease
Rohit Loomba et al.
CELL (2021)
Editorial: central obesity is a risk factor for hepatocellular carcinoma in Asian patients with chronic hepatitis B on anti-viral therapy
Terry Cheuk-Fung Yip et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2021)
Modelling NAFLD disease burden in four Asian regions-2019-2030
Chris Estes et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2020)
Positive Hepatitis B Core Antibody Is Associated With Cirrhosis and Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease
Ting Ting Chan et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2020)
A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement
Mohammed Eslam et al.
JOURNAL OF HEPATOLOGY (2020)
The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease
Mohammed Eslam et al.
HEPATOLOGY INTERNATIONAL (2020)
When a new definition overhauls perceptions of MAFLD related cirrhosis care
Kenneth I. Zheng et al.
HEPATOBILIARY SURGERY AND NUTRITION (2020)
Liver steatosis is a major predictor of poor outcomes in chronic hepatitis C patients with sustained virological response
Noam Peleg et al.
JOURNAL OF VIRAL HEPATITIS (2019)
Share Paper
